These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7715618)

  • 1. Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR 4233) and mitomycin C, under aerobic and hypoxic conditions.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Takagi T; Murata R; Abe M
    Mutat Res; 1995 Apr; 342(3-4):171-7. PubMed ID: 7715618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
    Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
    Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A; Godden J; Stratford IJ; Adams GE
    Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and implications for the mechanism of cytotoxicity observed in air.
    Tuttle SW; Hazard L; Koch CJ; Mitchell JB; Coleman CN; Biaglow JE
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):357-62. PubMed ID: 8195033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
    Zhang M; Stevens G
    Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
    Elwell JH; Siim BG; Evans JW; Brown JM
    Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.
    Stratford IJ; Stephens MA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):973-6. PubMed ID: 2495261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.
    Lin PS; Ho KC; Yang SJ
    Cancer Lett; 1996 Aug; 105(2):249-55. PubMed ID: 8697451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
    Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
    Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
    Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
    Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
    Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.
    Minchinton AI; Tonn DA; Sutherland DP; Kyle AH
    Radiat Res; 2002 Jul; 158(1):94-100. PubMed ID: 12071808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.
    Hanauske AR; Ross M; Degen D; Hilsenbeck SG; Von Hoff DD
    Eur J Cancer; 1993; 29A(3):423-5. PubMed ID: 8398345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of micronucleus induction in murine SCCVII cells treated with various anticancer agents.
    Jeremic B; Shibamoto Y; Abe M
    Chemotherapy; 1996; 42(4):266-72. PubMed ID: 8804794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
    Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
    Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
    Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
    Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.